Skybound Medtech

Skybound is building Texas’s first large-scale, dual-use space-medical technologies company. We develop the medical infrastructure needed to keep humans healthy during long-duration spaceflight while delivering high-value clinical and defense applications on Earth.
Houston

About Skybound Medtech

Skybound is building Texas’s first large-scale, dual-use space-medical technologies company. We develop the medical infrastructure needed to keep humans healthy during long-duration spaceflight while delivering high-value clinical and defense applications on Earth. Our mission is to create transformative medical devices, digital-health platforms, and medical-manufacturing capabilities that enable sustained human presence in space and establish a new industrial engine for Houston and the State of Texas.

Skybound operates as a technology developer, manufacturer, and commercialization engine: we run research programs, build manufacturable medical devices and platforms, launch spinouts, and attract investment to Texas. Skybound will create hundreds of new jobs and to found a new dual-use medtech economic sector that diversifies and grows Houston’s space and life-sciences economy.

Our work directly supports Texas’s role as a national hub for human spaceflight (centered on Johnson Space Center and Houston) and contributes to the state’s broader aerospace, life-science, and space-operations ecosystem. This effort strengthens Texas’s workforce, federal partnerships, and commercial leadership in human space systems.

Our core purpose is to remove the physiological limits on long-duration human presence off-planet by delivering the medical infrastructure and products necessary to keep people healthy in space. In doing so, we will create a scalable, high-value industrial cluster in Texas that serves space exploration, national defense, and civilian clinical markets—creating jobs, attracting federal and private capital, and positioning Texas as a leader in the emerging trillion-dollar space economy.

Tagged with

Team

Problem statement

Sustained human operations in space are approaching a hard limit because we do not have medical infrastructure that can reliably prevent, monitor, diagnose, and treat health events when resupply, bandwidth, and specialist expertise are constrained. Today’s space medical capability is a patchwork of protocols and one-off hardware—not a scalable, manufacturable, certifiable stack of devices, software, and production capacity. Until that gap is closed, long-duration missions remain high-risk and costly, and the dual-use clinical and defense value of space medicine will remain underdeveloped and under-deployed on Earth.

Traction information

- $7M in committed launch capital towards $25M initial raise
- Partnerships with Rice University, Texas A&M University, Trivedi Institute for Global Space Biomedicine, University City Science Center, Space Alliance Technology Outreach Program, and Capital Factory

Product images

Updates

Spurred by a lifelong passion for space, medicine, and engineering, I am excited to announce the launch of Skybound Medtech. Backed by $5M in early committed capital towards a $25M initial raise and partnering with Texas A&M School of Engineering Medicine (EnMed) / EnGen, Rice Innovation & Rice Nexus, University City Science Center, SATOP, and a few more to be announced in the coming weeks, Skybound Medtech is developing a portfolio of transformative dual-use medical technologies at the intersection of space medicine, longevity medicine, and national defense.

We stand at the precipice of a burgeoning industrial revolution. The commercial space economy is projected to surge to $1 trillion by the early 2030s. This exponential growth curve is fueled by a twenty-fold increase in venture investment into space companies since 2016, driven largely by the plummeting costs of launch via reusable rocketry, efforts by nations around the world to develop sovereign military space capabilities, a rapidly growing market for space tourism, and the promise of new super materials enabled by in-space manufacturing.

However, while the infrastructure for reaching orbit continues to mature, the ability to keep humans in space is impaired by a critical bottleneck: human physiology. The deterioration of the human body in the extreme environment of space mirrors accelerated aging. The symptoms experienced by astronauts - bone loss, muscle wasting, vestibular decay - are clinically identical to natural aging on Earth. By engineering solutions to sustain human health in orbit, we are validating transformative longevity therapeutics for aging populations and autonomous healthcare solutions for austere environments on Earth.

We are proudly headquartered in Houston, Texas - the only city on the planet that offers a world-class, co-located ecosystem in life sciences (Texas Medical Center), human spaceflight (NASA's Johnson Space Center), and venture capital.

Over the next decade, Skybound will launch ten new medtech startups, each strategically focused on dual-use medical technologies to transform the standard of care for disease treatment and prevention while simultaneously paving the way for the Second Space Age. These startups will create 100+ new jobs and drive a self-sustaining influx of talent, investment, and non-dilutive capital into the Texas economy.

Profile created.
Added about 3 hours ago

Funding

Currently raising capital

$7,000,000
committed
$25,000,000
round goal
Total raised to date: $7,000,000
Pitch is a Capital Factory product. © Capital Factory 2024. Privacy policy.